Active ingredientDoxofyllineCat. No. P-D183-001CAS 69975-86-6Family · Pharmaceutical analytical standards
Doxofylline
A bronchodilator of the xanthine family, a theophylline derivative carrying a dioxolane ring: synthesised in Italy in the early 1960s and developed as a medicine in the late 1970s, it is used for asthma and chronic obstructive pulmonary disease. This family brings together the active ingredient, labelled standards and other impurities.
Did you know?Compared with theophylline it has much lower affinity for adenosine receptors, the binding blamed for part of the parent drug's unwanted effects.
Go to the active ingredient →Active ingredientDoxofyllineCat. No. P-D183-001CAS 69975-86-6
Isotopically labelledDoxofylline-d4Cat. No. P-D183-002CAS 1346599-13-0
ImpurityDoxofylline Impurity 1Cat. No. P-D183-003CAS 109403-76-1
Impurity7-(2',2'-Diethoxyethyl)theophyllineCat. No. P-D183-004CAS 43135-57-5
ImpurityDoxofylline Impurity 2Cat. No. P-D183-005CAS 1429636-72-5
ImpurityDoxofylline Impurity 3Cat. No. P-D183-006CAS 1021-65-4
ImpurityDoxofylline Impurity 4Cat. No. P-D183-007CAS 1174289-18-9
ImpurityDoxofylline Impurity 5Cat. No. P-D183-008CAS 254760-82-2
ImpurityDoxofylline Impurity 6Cat. No. P-D183-009CAS 1429636-74-7
ImpurityDoxofylline Impurity 7Cat. No. P-D183-010
ImpurityDoxofylline Impurity 8Cat. No. P-D183-011
ImpurityDoxofylline Impurity 9Cat. No. P-D183-012
ImpurityDoxofylline Impurity 10Cat. No. P-D183-014
ImpurityDoxofylline Impurity 11Cat. No. P-D183-015CAS 2095554-12-2
ImpurityDoxofylline Impurity 12Cat. No. P-D183-016CAS 2095485-27-9
ImpurityDoxofylline Impurity 13Cat. No. P-D183-017
ImpurityDoxofylline Impurity 14Cat. No. P-D183-018
ImpurityDoxofylline Impurity 15Cat. No. P-D183-019CAS 7029-96-1No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.